(Q44301265)

1 December 2017

title

Droperidol: should the black box be light gray? (English)

1 reference

1 December 2017

Mark Dershwitz

1

1 reference

1 December 2017

publication date

1 December 2002

1 reference

Journal of Clinical Anesthesia

1 December 2017

published in

1 reference

1 December 2017

volume

14

1 reference

1 December 2017

issue

8

1 reference

1 December 2017

page(s)

598-603

1 reference

Arrhythmia risk of antiemetic agents

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2802%2900445-2

7 January 2021

FDA "black box" warning regarding use of droperidol for postoperative nausea and vomiting: is it justified?

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2802%2900445-2

7 January 2021

Droperidol "box warning" warrants scrutiny

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2802%2900445-2

7 January 2021

The FDA droperidol warning: is it justified?

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2802%2900445-2

7 January 2021

Antipsychotic-related QTc prolongation, torsade de pointes and sudden death

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2802%2900445-2

7 January 2021

Torsade de pointes resulting from the addition of droperidol to an existing cytochrome P450 drug interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2802%2900445-2

7 January 2021

Cost-effectiveness of prophylactic antiemetic therapy with ondansetron, droperidol, or placebo.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2802%2900445-2

7 January 2021

Black-box warning for droperidol surprises pharmacists.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-8180%2802%2900445-2

7 January 2021

10.1016/S0952-8180(02)00445-2

Identifiers

DOI

1 reference

1 December 2017

1 reference